
Thor Halfdanarson/mayoclinic.org
Jun 18, 2025, 13:27
Thor Halfdanarson Highlighted New Surveillance Update in Von Hippel-Lindau Disease Published in Clinical Cancer Research
Thor Halfdanarson, Medical Oncologist at the Mayo Clinic, shared a post on X:
“I just posted highly valuable guidelines on MEN1, checked my e-mail and found this… Update in surveillance for VHL.
If you are interested in the NET as a manifestation of MEN1, there is a good chance you might be interested in VHL too… “
Title: Update on Surveillance in Von Hippel-Lindau Disease
Journal: Clinical Cancer Research, AACR
Authors: Surya P. Rednam, Kerri D. Becktell, Anita Villani, Garrett M. Brodeur, Lisa J. States, Andrea S. Doria, Junne Kamihara, Kami Wolfe Schneider, Stephan D. Voss, Elysa Widjaja, Kristin Zelley, Yoshiko Nakano, Kristian W. Pajtler, Maria Isabel Achatz, David Malkin, Lisa R. Diller, Bailey Gallinger, Chieko Tamura, Jonathan D. Wasserman
More posts featuring Thor Halfdanarson on OncoDaily.
AACR
Andrea S. Doria
Anita Villani
Bailey Gallinger
cancer
Chieko Tamura
Clinical Cancer Research
David Malkin
Elysa Widjaja
Garrett M. Brodeur
Jonathan D. Wasserman
Junne Kamihara
Kami Wolfe Schneider
Kerri D. Becktell
Kristian W. Pajtler
Kristin Zelley
Lisa J. States
Lisa R. Diller
Maria Isabel Achatz
Mayo Clinic
MEN1
OncoDaily
Oncology
Stephan D. Voss
Surya P. Rednam
Thor Halfdanarson
VHL
Von Hippel-Lindau disease
Yoshiko Nakano
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 18, 2025, 13:22
Jun 18, 2025, 13:03
Jun 18, 2025, 10:57
Jun 18, 2025, 10:16